Rising Gabapentin Prescriptions Spotlight Need for Safety Awareness
Gabapentin prescriptions have surged in recent years, highlighting the need for increased awareness of its potential adverse effects and safe prescribing practices.
Recent research highlights a significant uptick in gabapentin dispensing across the United States, emphasizing the importance of understanding its potential adverse effects. A comprehensive analysis of pharmacy data from 2010 to 2024 reveals that gabapentin, initially prescribed at relatively modest rates, saw a steady increase over the years. By 2024, it had become the fifth most prescribed medication, up from the tenth position in 2017. This trend is partly driven by expanded prescribing rights for nurse practitioners and physician assistants, reflecting shifts in healthcare practices.
The study, published in the Annals of Internal Medicine, assessed prescription trends using data from IQVIA’s National Prescription Audit and the Total Patient Tracker database. It found that prescription rates rose from 79.5 per 1,000 persons in 2010 to 177.6 per 1,000 in 2024, while the number of individuals receiving gabapentin increased from 18.9 to 46.9 per 1,000. These figures doubled between 2010 and 2016, but the rate of growth slowed afterward.
Given gabapentin’s widespread use, healthcare providers, particularly physicians and advanced practice clinicians, must remain vigilant regarding its potential adverse effects. The rise in prescriptions underscores the necessity of appropriate patient monitoring and awareness of risks associated with off-label and long-term use. As prescribing patterns evolve, ongoing education about medication safety becomes increasingly essential to mitigate possible harms.
This data points to an urgent need for continuous review of prescribing practices, ensuring patient safety remains a priority amidst changing healthcare dynamics. For more detailed insights, the full study is available in the Annals of Internal Medicine, authored by Andrea E. Strahan and colleagues. Source: MedicalXpress
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Advances in Home Care for Children with Acute Gastroenteritis Based on Recent Research
New research confirms that providing ondansetron to children with gastroenteritis at discharge helps prevent recurrence of vomiting and supports at-home recovery, leading to improved pediatric emergency care.
Study Finds No Significant Benefits of Mavacamten in Patients with Nonobstructive Hypertrophic Cardiomyopathy
A large phase III trial reveals that mavacamten does not significantly improve symptoms or exercise capacity in patients with nonobstructive hypertrophic cardiomyopathy, highlighting the need for new therapeutic strategies.
Open-Source Health Data Repository Empowers AI Research in Medicine
The University of Toronto launches the Health Data Nexus, an open-source, secure platform that empowers AI-driven medical research by making diverse, de-identified health data widely accessible for innovative healthcare solutions.
Harnessing Digital Technology to Revolutionize Pediatric Nursing
Explore how digital technology, including AI, wearable sensors, and virtual tools, is transforming pediatric nursing by enhancing safety, personalization, and overall patient experience.